In this context, it is essential to maintain a high index of suspicion with at-risk patients (older male smokers with squamous cell lung cancer, respiratory or autoimmune comorbidity, and exposure to anti-PD1, combinations of immunotherapy, or previous thoracic radiotherapy) to facilitate early diagnosis and treatment that could improve prognosis. This evidence concerns the gene PDCD1 and squamous cell lung carcinoma.